Event Type
Disclosure
Voluntary
Variant
8-K
, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (t
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Ernexa Therapeutics Investor Presentation – February 2026. 104 Cover Page Inter